Quintiles, a global biopharmaceutical services company, has been named “Best Clinical Research Organization” (CRO) in the Vaccine Industry Excellence (ViE) Awards 2012, which recognizes and celebrates the leaders, innovators and pioneers in the vaccines industry.
“This is a great honor to be recognized as the “Best CRO” at the World Vaccine Congress,” said Dr. Ellen Vigdorth, VP Allergy, Respiratory, Infectious Diseases and Vaccines. “It is a huge achievement and underscores our commitment to the development of quality vaccines and anti-infective products.
Customers voted for their preferred CRO prior to the World Vaccine Congress; a judging panel then made its selection based on the following criteria: 1) Range of services provided in niche and core therapeutic areas; 2) Methods of performance improvement or introduction of new services; 3) Attention to and quality of relationships with clients; 4) Reaching of milestones and final/ongoing outcomes; 5) Building and maintaining existing and long-term partnerships.
This award comes shortly after Quintiles was named, for the second year running, the 2012 “Asia Pacific CRO of the Year” at the BioPharma Convention Awards.